Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease.

Alteration of brain aerobic glycolysis is often observed early in the course of Alzheimer's disease (AD). Whether and how such metabolic dysregulation contributes to both synaptic plasticity and behavioral deficits in AD is not known. Here, we show that the astrocytic l-serine biosynthesis pathway, which branches from glycolysis, is impaired in young AD mice and in AD patients. l-serine is the precursor of d-serine, a co-agonist of synaptic NMDA receptors (NMDARs) required for synaptic plasticity. Accordingly, AD mice display a lower occupancy of the NMDAR co-agonist site as well as synaptic and behavioral deficits. Similar deficits are observed following inactivation of the l-serine synthetic pathway in hippocampal astrocytes, supporting the key role of astrocytic l-serine. Supplementation with l-serine in the diet prevents both synaptic and behavioral deficits in AD mice. Our findings reveal that astrocytic glycolysis controls cognitive functions and suggest oral l-serine as a ready-to-use therapy for AD.

[1]  F. Ciruela,et al.  l-Serine dietary supplementation is associated with clinical improvement of loss-of-function GRIN2B-related pediatric encephalopathy , 2019, Science Signaling.

[2]  Angus M. Brown,et al.  Current technical approaches to brain energy metabolism , 2018, Glia.

[3]  Pierre J. Magistretti,et al.  Lactate in the brain: from metabolic end-product to signalling molecule , 2018, Nature Reviews Neuroscience.

[4]  L. Ferrucci,et al.  Evidence for brain glucose dysregulation in Alzheimer's disease , 2018, Alzheimer's & Dementia.

[5]  B. Weber,et al.  CrossTalk proposal: an important astrocyte‐to‐neuron lactate shuttle couples neuronal activity to glucose utilisation in the brain , 2018, The Journal of physiology.

[6]  Andrew J. Saykin,et al.  Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study , 2018, The Lancet Neurology.

[7]  L. K. Bak,et al.  CrossTalk opposing view: lack of evidence supporting an astrocyte‐to‐neuron lactate shuttle coupling neuronal activity to glucose utilisation in the brain , 2018, The Journal of physiology.

[8]  H. Lane,et al.  Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging , 2017, Scientific Reports.

[9]  Joana S. Ferreira,et al.  Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses , 2017, eLife.

[10]  F. LaFerla,et al.  Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony , 2017, Trends in Neurosciences.

[11]  Marina Boccardi,et al.  Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework , 2017, Neurobiology of Aging.

[12]  P. Cox,et al.  Traditional Food Items in Ogimi, Okinawa: l-Serine Content and the Potential for Neuroprotection , 2017, Current Nutrition Reports.

[13]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[14]  Robert G. Miller,et al.  Phase I clinical trial of safety of L-serine for ALS patients , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[15]  M. Ahissar,et al.  Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. , 2016, Brain : a journal of neurology.

[16]  M. V. Vander Heiden,et al.  The importance of serine metabolism in cancer , 2016, The Journal of cell biology.

[17]  Norbert Schuff,et al.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.

[18]  M. Verbeek,et al.  CSF d-serine concentrations are similar in Alzheimer's disease, other dementias, and elderly controls , 2016, Neurobiology of Aging.

[19]  B. Lambolez,et al.  Nicotinic Transmission onto Layer 6 Cortical Neurons Relies on Synaptic Activation of Non-α7 Receptors. , 2016, Cerebral cortex.

[20]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[21]  Marc Dhenain,et al.  High-throughput 3D whole-brain quantitative histopathology in rodents , 2016, Scientific Reports.

[22]  H. Sugimoto,et al.  Bioanalytical method for the simultaneous determination of D- and L-serine in human plasma by LC/MS/MS. , 2015, Analytical biochemistry.

[23]  W. Chung,et al.  Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination , 2015, Journal of Medical Genetics.

[24]  Pierre J. Magistretti,et al.  A Cellular Perspective on Brain Energy Metabolism and Functional Imaging , 2015, Neuron.

[25]  J. Laks,et al.  d-serine levels in Alzheimer's disease: implications for novel biomarker development , 2015, Translational Psychiatry.

[26]  K. Janes.  An analysis of critical factors for quantitative immunoblotting , 2015, Science Signaling.

[27]  Jesse D. Sengillo,et al.  GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration , 2015, Nature Neuroscience.

[28]  A. McDonough,et al.  Considerations when quantitating protein abundance by immunoblot. , 2015, American journal of physiology. Cell physiology.

[29]  B. Weber,et al.  Channel-Mediated Lactate Release by K+-Stimulated Astrocytes , 2015, The Journal of Neuroscience.

[30]  J. Sahel,et al.  Repair of Rhodopsin mRNA by Spliceosome-Mediated RNA Trans-Splicing: A New Approach for Autosomal Dominant Retinitis Pigmentosa , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  Andrei G. Vlassenko,et al.  Brain aerobic glycolysis functions and Alzheimer’s disease , 2015, Clinical and Translational Imaging.

[32]  Ann D. Cohen,et al.  Early detection of Alzheimer's disease using PiB and FDG PET , 2014, Neurobiology of Disease.

[33]  A. Hoischen,et al.  Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway. , 2014, American journal of human genetics.

[34]  Yong Jeong,et al.  GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease , 2014, Nature Medicine.

[35]  Pascal Jourdain,et al.  Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons , 2014, Proceedings of the National Academy of Sciences.

[36]  Bradley T. Hyman,et al.  The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease , 2014, Neuron.

[37]  S. Snyder,et al.  d-Serine in Glia and Neurons Derives from 3-Phosphoglycerate Dehydrogenase , 2013, The Journal of Neuroscience.

[38]  J. Alferink,et al.  Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior , 2013, PloS one.

[39]  Antonia García,et al.  Optimization and validation of a capillary electrophoresis laser‐induced fluorescence method for amino acids determination in human plasma: Application to bipolar disorder study , 2013, Electrophoresis.

[40]  T. Coşkun,et al.  An update on serine deficiency disorders , 2013, Journal of Inherited Metabolic Disease.

[41]  G. Alexander,et al.  Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. , 2013, JAMA neurology.

[42]  Alejandro San Martín,et al.  A Genetically Encoded FRET Lactate Sensor and Its Use To Detect the Warburg Effect in Single Cancer Cells , 2013, PloS one.

[43]  D. Attwell,et al.  Synaptic Energy Use and Supply , 2012, Neuron.

[44]  S. Oliet,et al.  Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists , 2012, Cell.

[45]  T. Hornemann,et al.  Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. , 2011, The Journal of clinical investigation.

[46]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[47]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[48]  L. Schneider,et al.  Lack of evidence for the efficacy of memantine in mild Alzheimer disease. , 2011, Archives of neurology.

[49]  Abhishek K. Jha,et al.  Functional genomics reveals serine synthesis is essential in PHGDH-amplified breast cancer , 2011 .

[50]  D. Barbier,et al.  Covalent enzyme immobilization by poly(ethylene glycol) diglycidyl ether (PEGDE) for microelectrode biosensor preparation. , 2011, Biosensors & bioelectronics.

[51]  Sarah A. Stern,et al.  Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation , 2011, Cell.

[52]  T. Ohshima,et al.  Soy Peptide Ingestion Increases Neuroactive Amino Acids in the Adult Brain of Wild-Type and Genetically Engineered Serine-Deficient Mice , 2011 .

[53]  Masahiko Watanabe,et al.  Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult Brain* , 2010, The Journal of Biological Chemistry.

[54]  E. Mufson,et al.  Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis , 2010, International journal of Alzheimer's disease.

[55]  Vincent Frouin,et al.  Validation of MRI-based 3D digital atlas registration with histological and autoradiographic volumes: An anatomofunctional transgenic mouse brain imaging study , 2010, NeuroImage.

[56]  Marc Dhenain,et al.  Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease , 2010, NeuroImage.

[57]  A. Halestrap,et al.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10 , 2009, The Biochemical journal.

[58]  S. Oliet,et al.  Long term potentiation depends on release of D-serine from astrocytes , 2009, Nature.

[59]  S. Moncada,et al.  The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1 , 2009, Nature Cell Biology.

[60]  Vincent Frouin,et al.  Quantitative validation of voxel-wise statistical analyses of autoradiographic rat brain volumes: Application to unilateral visual stimulation , 2008, NeuroImage.

[61]  E. Head,et al.  Lack of Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease after Overexpression of the Anti-Apoptotic Protein Bcl-2 , 2008, The Journal of Neuroscience.

[62]  Loredano Pollegioni,et al.  Characterization of a yeast D-amino acid oxidase microbiosensor for D-serine detection in the central nervous system. , 2007, Analytical chemistry.

[63]  M. D. de Leon,et al.  Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[64]  S. Oliet,et al.  Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory , 2006, Cell.

[65]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[66]  L. Dorland,et al.  Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency , 2004, The Lancet.

[67]  M. Poo,et al.  Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[69]  K. Willecke,et al.  hGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo , 2001, Genesis.

[70]  Daniel Rueckert,et al.  Nonrigid registration using free-form deformations: application to breast MR images , 1999, IEEE Transactions on Medical Imaging.

[71]  I. Silver,et al.  Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[72]  R. Morris.  Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[73]  Sholl Da.  Dendritic organization in the neurons of the visual and motor cortices of the cat. , 1953 .

[74]  D. Sholl.  Dendritic organization in the neurons of the visual and motor cortices of the cat. , 1953, Journal of anatomy.